Damora Therapeutics
DMRA
#5408
Rank
NZ$2.62 B
Marketcap
NZ$42.45
Share price
-4.44%
Change (1 day)
42.12%
Change (1 year)

Earnings for Damora Therapeutics (DMRA)

Earnings in 2026 (TTM): -NZ$0.51 Billion

According to Damora Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.39 Billion a decrease over its 2024 earnings that were of -NZ$39.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Damora Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.51 Billion31.94%
2025 -NZ$0.39 Billion880.41%
2024 -NZ$39.12 Million-44.2%
2023 -NZ$70.11 Million-37.77%
2022 -NZ$0.12 Billion19.08%
2021 -NZ$94.61 Million48.55%
2020 -NZ$63.69 Million